JP2008536488A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008536488A5 JP2008536488A5 JP2008502127A JP2008502127A JP2008536488A5 JP 2008536488 A5 JP2008536488 A5 JP 2008536488A5 JP 2008502127 A JP2008502127 A JP 2008502127A JP 2008502127 A JP2008502127 A JP 2008502127A JP 2008536488 A5 JP2008536488 A5 JP 2008536488A5
- Authority
- JP
- Japan
- Prior art keywords
- probe set
- affymetrix
- seq
- kit
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 claims description 102
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 12
- 102100027849 Homeobox protein GBX-2 Human genes 0.000 claims description 9
- 101000859754 Homo sapiens Homeobox protein GBX-2 Proteins 0.000 claims description 9
- 239000002299 complementary DNA Substances 0.000 claims description 3
- 230000014509 gene expression Effects 0.000 claims 22
- 102100036817 Ankyrin-3 Human genes 0.000 claims 13
- 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 claims 13
- 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 claims 13
- 101000928342 Homo sapiens Ankyrin-3 Proteins 0.000 claims 13
- 101000938676 Homo sapiens Liver carboxylesterase 1 Proteins 0.000 claims 13
- 101000945496 Homo sapiens Proliferation marker protein Ki-67 Proteins 0.000 claims 13
- 102100031347 Metallothionein-2 Human genes 0.000 claims 13
- 102100034836 Proliferation marker protein Ki-67 Human genes 0.000 claims 13
- 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 claims 11
- 101000868643 Homo sapiens G2/mitotic-specific cyclin-B1 Proteins 0.000 claims 11
- 101000896657 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 Proteins 0.000 claims 11
- 102100021691 Mitotic checkpoint serine/threonine-protein kinase BUB1 Human genes 0.000 claims 11
- 102100037964 E3 ubiquitin-protein ligase RING2 Human genes 0.000 claims 8
- 101001095815 Homo sapiens E3 ubiquitin-protein ligase RING2 Proteins 0.000 claims 8
- 101001112162 Homo sapiens Kinetochore protein NDC80 homolog Proteins 0.000 claims 8
- 101000807524 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 22 Proteins 0.000 claims 8
- 102000018726 Host Cell Factor C1 Human genes 0.000 claims 8
- 108010027310 Host Cell Factor C1 Proteins 0.000 claims 8
- 102100023890 Kinetochore protein NDC80 homolog Human genes 0.000 claims 8
- 102100037184 Ubiquitin carboxyl-terminal hydrolase 22 Human genes 0.000 claims 8
- 238000005259 measurement Methods 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 230000001394 metastastic effect Effects 0.000 claims 3
- 206010061289 metastatic neoplasm Diseases 0.000 claims 3
- 210000004881 tumor cell Anatomy 0.000 claims 3
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 239000007790 solid phase Substances 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 230000004083 survival effect Effects 0.000 claims 2
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims 1
- 208000000172 Medulloblastoma Diseases 0.000 claims 1
- 206010027406 Mesothelioma Diseases 0.000 claims 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010066901 Treatment failure Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 230000009545 invasion Effects 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 210000001428 peripheral nervous system Anatomy 0.000 claims 1
- 208000023958 prostate neoplasm Diseases 0.000 claims 1
- 238000011471 prostatectomy Methods 0.000 claims 1
- 238000002271 resection Methods 0.000 claims 1
- 210000001625 seminal vesicle Anatomy 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 201000010653 vesiculitis Diseases 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 101150000874 11 gene Proteins 0.000 description 1
- SOBMVBSSEJZEBX-UHFFFAOYSA-N 2-[2,2-bis(2-octadecanoyloxyethoxymethyl)butoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCC(CC)(COCCOC(=O)CCCCCCCCCCCCCCCCC)COCCOC(=O)CCCCCCCCCCCCCCCCC SOBMVBSSEJZEBX-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66301405P | 2005-03-16 | 2005-03-16 | |
| PCT/US2006/009870 WO2006110264A2 (en) | 2005-03-16 | 2006-03-16 | Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009061926A Division JP2009131278A (ja) | 2005-03-16 | 2009-03-13 | 遺伝子発現署名を使用する、癌による死亡および前立腺癌生存率を予測するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008536488A JP2008536488A (ja) | 2008-09-11 |
| JP2008536488A5 true JP2008536488A5 (https=) | 2009-05-07 |
Family
ID=37087482
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008502127A Pending JP2008536488A (ja) | 2005-03-16 | 2006-03-16 | 遺伝子発現署名を使用する、癌による死亡および前立腺癌生存率を予測するための方法および組成物 |
| JP2009061926A Pending JP2009131278A (ja) | 2005-03-16 | 2009-03-13 | 遺伝子発現署名を使用する、癌による死亡および前立腺癌生存率を予測するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009061926A Pending JP2009131278A (ja) | 2005-03-16 | 2009-03-13 | 遺伝子発現署名を使用する、癌による死亡および前立腺癌生存率を予測するための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8349555B2 (https=) |
| EP (1) | EP1874471A4 (https=) |
| JP (2) | JP2008536488A (https=) |
| AU (1) | AU2006234897A1 (https=) |
| WO (1) | WO2006110264A2 (https=) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130122504A1 (en) * | 2011-11-14 | 2013-05-16 | Lars Dyrskjot Andersen | Expression Levels of COL4A3BP and other Markers Correlating with Progression or Non-Progression of Bladder Cancer |
| EP1915622A2 (en) * | 2005-07-29 | 2008-04-30 | Oncotherapy Science, Inc. | Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| CN103424541B (zh) | 2006-05-18 | 2018-01-30 | 分子压型学会股份有限公司 | 确定针对病状的个性化医疗介入的系统和方法 |
| US8768629B2 (en) * | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
| WO2008058018A2 (en) | 2006-11-02 | 2008-05-15 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| DE102007044919A1 (de) * | 2007-09-19 | 2009-04-02 | Hefter, Harald, Prof. Dr. med. Dr. rer. nat. | Verfahren zur Bestimmung von sekundärem Therapieversagen |
| WO2009084740A1 (ja) * | 2007-12-28 | 2009-07-09 | National University Corporation Nagoya University | 肺腺癌患者の術後再発を予測するための方法及び組成物 |
| AU2009253675A1 (en) * | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US8227202B2 (en) | 2008-07-10 | 2012-07-24 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
| WO2010045318A2 (en) * | 2008-10-14 | 2010-04-22 | Caris Mpi, Inc. | Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type |
| JP5461959B2 (ja) * | 2008-10-31 | 2014-04-02 | 株式会社Ｄｎａチップ研究所 | 神経膠腫予後予測方法、およびそれに用いるキット |
| WO2010056337A2 (en) | 2008-11-12 | 2010-05-20 | Caris Mpi, Inc. | Methods and systems of using exosomes for determining phenotypes |
| EP2433232A1 (en) * | 2009-05-20 | 2012-03-28 | Koninklijke Philips Electronics N.V. | Biomarkers based on sets of molecular signatures |
| EP2542696B1 (en) | 2010-03-01 | 2016-09-28 | Caris Life Sciences Switzerland Holdings GmbH | Biomarkers for theranostics |
| JP2013526852A (ja) | 2010-04-06 | 2013-06-27 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | 疾患に対する循環バイオマーカー |
| IL243203A (en) | 2010-07-27 | 2017-04-30 | Genomic Health Inc | Method for using gene expression to determine prognosis of prostate cancer |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| WO2013093644A2 (en) * | 2011-11-23 | 2013-06-27 | Uti Limited Partnership | Expression signature for staging and prognosis of prostate, breast and leukemia cancers |
| US10513737B2 (en) | 2011-12-13 | 2019-12-24 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| DK3179393T3 (da) | 2012-01-31 | 2020-07-27 | Genomic Health Inc | Genexpressionsprofilalgoritme og -test til bestemmelse af prognosen for prostatakræft |
| EP2885640B1 (en) | 2012-08-16 | 2018-07-18 | Genomedx Biosciences, Inc. | Prostate cancer prognostics using biomarkers |
| CA2884737A1 (en) * | 2012-08-16 | 2014-02-20 | The Trustees Of Columbia University In The City Of New York | Diagnostic markers of indolent prostate cancer |
| KR101993716B1 (ko) * | 2012-09-28 | 2019-06-27 | 삼성전자주식회사 | 카테고리별 진단 모델을 이용한 병변 진단 장치 및 방법 |
| US9687290B2 (en) | 2012-10-02 | 2017-06-27 | Covidien Lp | Energy-based medical devices |
| TWI658049B (zh) * | 2013-03-12 | 2019-05-01 | 腫瘤療法 科學股份有限公司 | Ｋｎｔｃ２胜肽及含此胜肽之疫苗 |
| WO2014144476A1 (en) * | 2013-03-15 | 2014-09-18 | The Broad Institute, Inc. | Methods for the detection of dna-rna proximity in vivo |
| WO2014210611A1 (en) * | 2013-06-28 | 2014-12-31 | Nantomics, Llc | Pathway analysis for identification of diagnostic tests |
| ES2923942T3 (es) | 2013-11-06 | 2022-10-03 | Us Health | Procedimiento para el subtipado de tipos de linfoma por medio de perfiles de expresión |
| GB201322034D0 (en) | 2013-12-12 | 2014-01-29 | Almac Diagnostics Ltd | Prostate cancer classification |
| FR3017955B1 (fr) * | 2014-02-27 | 2018-04-06 | Assistance Publique - Hopitaux De Paris | Biomarqueurs diagnostics de la cardiomyopathie du peripartum |
| WO2016036878A1 (en) * | 2014-09-02 | 2016-03-10 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
| TWI582240B (zh) * | 2015-05-19 | 2017-05-11 | 鄭鴻鈞 | 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置 |
| JP6991134B2 (ja) * | 2015-10-09 | 2022-01-12 | ガーダント ヘルス， インコーポレイテッド | 無細胞ｄｎａを使用する集団ベースの処置レコメンダ |
| JP7075896B2 (ja) | 2016-04-20 | 2022-05-26 | アメリカ合衆国 | マントル細胞リンパ腫の評価及びそれに関連する方法 |
| JP6963009B2 (ja) | 2016-05-19 | 2021-11-05 | オンコスカー エルエルシーOncoscar Llc | 臨床的に難治性の悪性腫瘍の診断及び治療標的化の方法 |
| EP3504348B1 (en) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| WO2018132916A1 (en) | 2017-01-20 | 2018-07-26 | Genomedx Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| CA3055925A1 (en) | 2017-03-09 | 2018-09-13 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| AU2018266733A1 (en) | 2017-05-12 | 2020-01-16 | Veracyte, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness |
| WO2019028285A2 (en) | 2017-08-04 | 2019-02-07 | Genomedx, Inc. | USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY |
| EP3715476A1 (en) * | 2019-03-29 | 2020-09-30 | Centre National De La Recherche Scientifique | Prognosis method of cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218122B1 (en) * | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
| US6203987B1 (en) * | 1998-10-27 | 2001-03-20 | Rosetta Inpharmatics, Inc. | Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |
| NL1014106C2 (nl) | 2000-01-18 | 2001-07-20 | Univ Amsterdam | Werkwijze voor het detecteren van een pathologische afwijking bij een cel, een antistof en een assay kit. |
| EP1410011B1 (en) * | 2001-06-18 | 2011-03-23 | Rosetta Inpharmatics LLC | Diagnosis and prognosis of breast cancer patients |
| AU2002358279A1 (en) | 2001-12-21 | 2003-07-30 | Arcturus Engineering, Inc. | Biomarkers for breast cancer |
| WO2004025258A2 (en) * | 2002-09-10 | 2004-03-25 | Sydney Kimmel Cancer Center | Gene segregation and biological sample classification methods |
| WO2004079014A2 (en) * | 2003-03-04 | 2004-09-16 | Arcturus Bioscience, Inc. | Signatures of er status in breast cancer |
| US8065093B2 (en) * | 2004-10-06 | 2011-11-22 | Agency For Science, Technology, And Research | Methods, systems, and compositions for classification, prognosis, and diagnosis of cancers |
| WO2006060646A2 (en) * | 2004-12-03 | 2006-06-08 | Board Of Regents, The University Of Texas System | Cell microarray for profiling of cellular phenotypes and gene function |
| US20090098538A1 (en) * | 2006-03-31 | 2009-04-16 | Glinsky Gennadi V | Prognostic and diagnostic method for disease therapy |
| CA2648021A1 (en) * | 2006-03-31 | 2007-10-11 | Ordway Research Institute, Inc. | Prognostic and diagnostic method for cancer therapy |
-
2006
- 2006-03-16 AU AU2006234897A patent/AU2006234897A1/en not_active Abandoned
- 2006-03-16 WO PCT/US2006/009870 patent/WO2006110264A2/en not_active Ceased
- 2006-03-16 EP EP06748441A patent/EP1874471A4/en not_active Withdrawn
- 2006-03-16 JP JP2008502127A patent/JP2008536488A/ja active Pending
- 2006-03-16 US US11/908,775 patent/US8349555B2/en not_active Expired - Fee Related
-
2009
- 2009-03-13 JP JP2009061926A patent/JP2009131278A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008536488A5 (https=) | ||
| ES2636470T3 (es) | Marcadores de expresión génica para predecir la respuesta a la quimioterapia | |
| EP1410011B1 (en) | Diagnosis and prognosis of breast cancer patients | |
| KR101530689B1 (ko) | 직장결장암용 예후 예측 | |
| KR101566368B1 (ko) | 암 검출을 위한 소변 유전자 발현 비율 | |
| CN106414774B (zh) | 胆道癌的检测试剂盒或装置以及检测方法 | |
| JP6404304B2 (ja) | メラノーマ癌の予後予測 | |
| CN105431737B (zh) | 用于预测局部晚期胃癌预后的系统 | |
| CN105316341B (zh) | 一种LncRNA及其在作为前列腺癌检测标记物或前列腺癌预后复发标记物中的应用 | |
| CN110551819B (zh) | 一组卵巢癌预后相关基因的应用 | |
| CN106978480A (zh) | 用于癌症的分子诊断试验 | |
| JP4435259B2 (ja) | 微量胃癌細胞の検出法 | |
| WO2012093821A2 (ko) | 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 | |
| AU2016263590A1 (en) | Methods and compositions for diagnosing or detecting lung cancers | |
| KR101847815B1 (ko) | 삼중음성유방암의 아형 분류 방법 | |
| KR20200002241A (ko) | 비만 진단을 위한 마이크로RNA-26b 또는 마이크로RNA-4449 바이오마커 및 이의 용도 | |
| CN110229899A (zh) | 用于结直肠癌早期诊断或预后预测的血浆标记物组合 | |
| CN108949969A (zh) | 长链非编码rna在结直肠癌中的应用 | |
| US7601532B2 (en) | Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma | |
| EP1683862A1 (en) | Microarray for assessing neuroblastoma prognosis and method of assessing neuroblastoma prognosis | |
| US20090297506A1 (en) | Classification of cancer | |
| WO2012056047A1 (en) | Metagene expression signature for prognosis of breast cancer patients | |
| WO2007137366A1 (en) | Diagnostic and prognostic indicators of cancer | |
| WO2005080570A1 (ja) | 乳癌の術後予後予測に関与する遺伝子 | |
| JP2019076068A (ja) | 卵巣癌組織型鑑別方法 |